AC Immune’s new immunotherapy just dropped some seriously hopeful news for people with early Parkinson’s. Their Phase 2 trial shows the treatment might actually slow down the disease’s progression—yep, you read that right! The therapy triggered a strong antibody response and kept key disease markers stable, which could mean less nerve damage over time. The stock is popping, and final results are due in 2026. Could this be a game-changer? #Health #BodyHealth #Parkinsons